These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 15653109)

  • 41. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.
    Niizeki T; Takeishi Y; Arimoto T; Takabatake N; Nozaki N; Hirono O; Watanabe T; Nitobe J; Harada M; Suzuki S; Koyama Y; Kitahara T; Sasaki T; Kubota I
    J Card Fail; 2007 Mar; 13(2):120-7. PubMed ID: 17395052
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic and prognostic impact of brain natriuretic peptide in cardiac and noncardiac diseases.
    Zakynthinos E; Kiropoulos T; Gourgoulianis K; Filippatos G
    Heart Lung; 2008; 37(4):275-85. PubMed ID: 18620103
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Possible vascular role of increased plasma arginine vasopressin in congestive heart failure.
    Nakamura T; Funayama H; Yoshimura A; Tsuruya Y; Saito M; Kawakami M; Ishikawa SE
    Int J Cardiol; 2006 Jan; 106(2):191-5. PubMed ID: 16321691
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of prolonged strenuous exercise on plasma levels of atrial natriuretic peptide and brain natriuretic peptide in healthy men.
    Ohba H; Takada H; Musha H; Nagashima J; Mori N; Awaya T; Omiya K; Murayama M
    Am Heart J; 2001 May; 141(5):751-8. PubMed ID: 11320362
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brain natriuretic peptide for prediction of Cheyne-Stokes respiration in heart failure patients.
    Christ M; Sharkova Y; Fenske H; Rostig S; Herzum I; Becker HF; Mueller C; Grimm W
    Int J Cardiol; 2007 Mar; 116(1):62-9. PubMed ID: 16820230
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.
    Mukoyama M; Nakao K; Hosoda K; Suga S; Saito Y; Ogawa Y; Shirakami G; Jougasaki M; Obata K; Yasue H
    J Clin Invest; 1991 Apr; 87(4):1402-12. PubMed ID: 1849149
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurohormonal risk stratification for sudden death and death owing to progressive heart failure in chronic heart failure.
    Berger R; Huelsmann M; Strecker K; Moertl D; Moser P; Bojic A; Pacher R
    Eur J Clin Invest; 2005 Jan; 35(1):24-31. PubMed ID: 15638816
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Persistent high NTpro-BNP concentration as a negative prognostic factor in patients with decompensated heart failure.
    Kubler P; Petruk-Kowalczyk J; Majda J; Reczuch K; Banasiak W; Ponikowski P
    Kardiol Pol; 2006 Mar; 64(3):250-6; discussion 257-8. PubMed ID: 16583323
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic value of increased plasma levels of brain natriuretic peptide in patients with septic shock.
    Ueda S; Nishio K; Akai Y; Fukushima H; Ueyama T; Kawai Y; Masui K; Yoshioka A; Okuchi K
    Shock; 2006 Aug; 26(2):134-9. PubMed ID: 16878020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Usefulness of intermediate amino-terminal pro-brain natriuretic peptide concentrations for diagnosis and prognosis of acute heart failure.
    van Kimmenade RR; Pinto YM; Bayes-Genis A; Lainchbury JG; Richards AM; Januzzi JL
    Am J Cardiol; 2006 Aug; 98(3):386-90. PubMed ID: 16860029
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure.
    Tsutamoto T; Tanaka T; Sakai H; Ishikawa C; Fujii M; Yamamoto T; Horie M
    Eur Heart J; 2007 Jul; 28(14):1723-30. PubMed ID: 17507366
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living with Heart Failure Questionnaire in an outpatient cohort with congestive heart failure.
    Hülsmann M; Berger R; Sturm B; Bojic A; Woloszczuk W; Bergler-Klein J; Pacher R
    Eur Heart J; 2002 Jun; 23(11):886-91. PubMed ID: 12042010
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time.
    Miller WL; Hartman KA; Burritt MF; Grill DE; Rodeheffer RJ; Burnett JC; Jaffe AS
    Circulation; 2007 Jul; 116(3):249-57. PubMed ID: 17592074
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
    Gegenhuber A; Struck J; Dieplinger B; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
    J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
    Ang DS; Kong CF; Kao MP; Struthers AD
    Am Heart J; 2009 Jul; 158(1):133-40. PubMed ID: 19540403
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure.
    Rudiger A; Gasser S; Fischler M; Hornemann T; von Eckardstein A; Maggiorini M
    Crit Care Med; 2006 Aug; 34(8):2140-4. PubMed ID: 16763507
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure.
    Tsukamoto O; Fujita M; Kato M; Yamazaki S; Asano Y; Ogai A; Okazaki H; Asai M; Nagamachi Y; Maeda N; Shintani Y; Minamino T; Asakura M; Kishimoto I; Funahashi T; Tomoike H; Kitakaze M
    J Am Coll Cardiol; 2009 Jun; 53(22):2070-7. PubMed ID: 19477358
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation.
    Wozakowska-Kapłon B; Opolski G
    Kardiol Pol; 2009 Mar; 67(3):254-61. PubMed ID: 19378231
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.